Naprogenix naprogenix.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Naprogenix has commercialized technology that aims to enable bio-prospecting (screening) of Kentucky native plants and mutant plants for molecules that could lead to plant-based medicines and natural insecticides. Founded in 2002, the company's current focus is on non-toxic insecticides, CNS-acting drugs and chemotherapeutic agents.

Naprogenix has commercialized technology that aims to enable bio-prospecting (screening) of Kentucky native plants and mutant plants for molecules that could lead to plant-based medicines and natural insecticides. Founded in 2002, the company's cur...Show all

Company (Alive / Active)

Phone:

Fax:

Lexington, 40502
Kentucky, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Naprogenix $0M Nov 30, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Naprogenix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Mutagenesis of plants for overproduction of selective estrogen receptor modulators Aug 07, 2015 Sep 12, 2017 Patent